ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Ampio’s inhaled drug lowers mortality in Covid-19 trial
April 28, 2021Ampio Pharmaceuticals has reported that its AP-014 Phase I clinical trial of inhaled drug Ampion showed a 78% improvement in all-cause mortality in Covid-19 patients with respiratory distress. -
Ampio reveals preliminary positive results on inhaled Ampion in Covid-19 respiratory distress
March 17, 2021Ampio Pharmaceuticals has revealed preliminary positive results of its AP-014 Phase I clinical trial that involves using of inhaled Ampion in treating respiratory distress in patients due to Covid-19.
Pharma Sources Insight January 2025
